During the recent session, Achieve Life Sciences Inc. (NASDAQ:ACHV)’s traded shares were 0.6 million, with the beta value of the company hitting 1.44. At the last check today, the stock’s price was $7.59, reflecting an intraday loss of -4.29% or -$0.34. The 52-week high for the ACHV share is $18.26, that puts it down -140.58 from that peak though still a striking 9.75% gain since the share price plummeted to a 52-week low of $6.85. The company’s market capitalization is $72.32M, and the average intraday trading volume over the past 10 days was 0.16 million shares, and the average trade volume was 230.70K shares over the past three months.
Achieve Life Sciences Inc. (ACHV) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.60. ACHV has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$1.22.
Achieve Life Sciences Inc. (NASDAQ:ACHV) trade information
Achieve Life Sciences Inc. (ACHV) registered a -4.29% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.29% in intraday trading to $7.59 this Wednesday, 07/21/21, hitting a weekly high. The stock’s 5-day price performance is 1.28%, and it has moved by 4.07% in 30 days. Based on these gigs, the overall price performance for the year is -27.11%. The short interest in Achieve Life Sciences Inc. (NASDAQ:ACHV) is 0.32 million shares and it means that shorts have 1.34 day(s) to cover.
The consensus price target of analysts on Wall Street is $42.83, which implies an increase of 82.28% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $21.00 and $100.00 respectively. As a result, ACHV is trading at a discount of -1217.52% off the target high and -176.68% off the low.
Achieve Life Sciences Inc. (ACHV) estimates and forecasts
Statistics show that Achieve Life Sciences Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Achieve Life Sciences Inc. (ACHV) shares have gone down -23.90% during the last six months, with a year-to-date growth rate less than the industry average at 10.15% against 16.70. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 27.40% this quarter and then jump 4.40% in the quarter after that.
While earnings are projected to return 86.40% in 2021, the next five years will return 15.00% per annum.
Achieve Life Sciences Inc. is due to release its next quarterly earnings between August 04 and August 09. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Achieve Life Sciences Inc. (NASDAQ:ACHV)’s Major holders
Achieve Life Sciences Inc. insiders own 0.31% of total outstanding shares while institutional holders control 17.08%, with the float percentage being 17.13%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 21 institutions own stock in it. As of Mar 30, 2021, the company held over 0.3 million shares (or 4.80% of all shares), a total value of $3.43 million in shares.
The next largest institutional holding, with 0.28 million shares, is of Ikarian Capital, LLC’s that is approximately 4.61% of outstanding shares. At the market price on Mar 30, 2021, these shares were valued at $3.29 million.
Also, the Mutual Funds coming in first place with the largest holdings of Achieve Life Sciences Inc. (ACHV) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Mar 30, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 0.24 million shares. This amounts to just over 3.88 percent of the company’s overall shares, with a $2.77 million market value. The same data shows that the other fund manager holds slightly less at 47311.0, or about 0.77% of the stock, which is worth about $0.55 million.